Drug
Cvncov Vaccine
Cvncov Vaccine: highest development phase Phase 3, developed by CureVac. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- CureVac
Trials
| Drug | Phase | Indication |
|---|---|---|
| CVnCoV Vaccine NCT04674189 | Phase 3 | Coronavirus |
| CVnCoV Vaccine NCT04838847 | Phase 3 | Coronavirus |
| CVnCoV Vaccine NCT04860258 | Phase 3 | Coronavirus |
| CVnCoV Vaccine NCT04449276 | Phase 1 | Severe Acute Respiratory Syndrome |
Latest
No recent events.
Follow Cvncov Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.